SEC Form 4 · accession 0001125345-17-000085
MACROGENICS INC · MGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ezio Bonvini
Officer — Sr VP, Research & CSO
Period of report
Jul 26, 2017
Accepted (ET)
Jul 27, 2017 · 4:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001125345
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 26, 2017 | M | 26,632 | $1.51 | A | 120,026 | D | |
| Common Stock | Jul 26, 2017 | M | 26,632 | $0.94 | A | 146,658 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy)F1 | $1.51 | Jul 26, 2017 | M | 26,632 | D | — | Jan 5, 2023 | Common Stock | 26,632 | 0 | D |
| Employee stock option (right to buy)F1 | $0.94 | Jul 26, 2017 | M | 26,632 | D | — | Mar 13, 2022 | Common Stock | 26,632 | 0 | D |
Explanation of responses
- F112.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter.